Glutathione IV Therapy

Glutathione is a powerful antioxidant naturally found in every cell of your body, made from three amino acids. It plays a vital role in protecting cells, supporting detoxification, and maintaining cellular balance. IV administration delivers glutathione directly into your bloodstream, bypassing the digestive system to achieve higher, more effective levels throughout your body.

IV glutathione has gained attention for supporting detoxification, reducing cellular stress, helping with neurological conditions, boosting immune function, and promoting overall wellness.

Overview

Glutathione exists in reduced (GSH) and oxidized (GSSG) forms, with the GSH/GSSG ratio serving as a critical indicator of cellular redox status. The unique gamma-peptide bond between glutamate and cysteine protects it from degradation by most peptidases. The cysteine thiol group (-SH) is responsible for glutathione's antioxidant properties and enables its role in detoxification through conjugation reactions.

Patient consulting with Dr. Ched Garten at Paragon, symbolizing advanced non-surgical care for joint, tendon, muscle, and pain issues.

Chemical structure & Properties

  • Molecular Formula: C₁₀H₁₇N₃O₆S
  • Molecular Weight: 307.32 Da
  • Structure: γ-L-Glutamyl-L-cysteinyl-glycine (Glu-Cys-Gly)
  • Chemical Class: Tripeptide thiol
  • Stability: Sensitive to oxidation; stabilized formulations required for IV use

Regulatory Status and

Clinical Use

FDA Status

Not FDA-approved specifically for IV therapeutic use; employed off-label by healthcare providers

Availability

Available through compounding pharmacies under physician prescription

Quality Assurance

Patients should ensure pharmaceutical-grade formulations from reputable, quality-controlled sources

Clinical Considerations

The Paragon Method: Step-by-Step

Administration and Treatment

  • Route: Intravenous infusion achieves significantly higher plasma concentrations than oral administration
  • Infusion Rate: 15-30 minutes recommended for optimal tolerance
  • Frequency: Varies from single sessions to regular protocols (weekly, bi-weekly, or monthly)
  • Duration: Depends on therapeutic goals and clinical response

Patient Selection

Ideal candidates include individuals with documented oxidative stress, chronic conditions with oxidative burden, those seeking medically indicated detoxification support, and patients with neurological conditions where evidence supports benefit.

Optimization Strategies

  • Adequate hydration before and after treatment
  • Nutritional support (selenium, B vitamins, sulfur-containing amino acids)
  • Lifestyle modifications reducing oxidative stress
  • Avoidance of alcohol during treatment periods

Monitoring

  • Regular assessment of therapeutic response
  • Monitoring for adverse effects
  • Periodic evaluation of oxidative stress markers when indicated
  • Treatment protocol adjustment based on clinical response
Man seated indoors with a soccer ball in natural light, representing Paragon’s musculoskeletal recovery expertise and regenerative treatment focus.

Conclusion

Glutathione IV therapy offers a promising approach for conditions involving cellular stress, antioxidant depletion, and impaired detoxification. IV delivery achieves much higher glutathione levels in your body than oral supplements can provide.

Clinical experience and growing research support its safety and potential benefits across many applications. While not FDA-approved for these specific uses, it's based on well-established science about how the body works, and many patients report positive outcomes.

References

Pizzorno J. Glutathione! Integr Med (Encinitas). 2014;13(1):8-12.

Sechi G, et al. Reduced intravenous glutathione in the treatment of early Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry. 1996;20(7):1159-1170.

Richie JP, et al. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. Eur J Nutr. 2015;54(2):251-263.

Hauser RA, et al. Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's disease. Mov Disord. 2009;24(7):979-983.

Wu G, et al. Glutathione metabolism and its implications for health. J Nutr. 2004;134(3):489-492.

Forman HJ, et al. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med. 2009;30(1-2):1-12.

Disclaimer: This information is provided for educational purposes only and does not constitute medical advice. Glutathione IV therapy is used off-label and has not been approved by the FDA specifically for the treatment of any disease. Patients should consult with qualified healthcare providers before considering any IV therapy. The content reflects current scientific literature and clinical practice as of 2025. Individual results may vary, and treatment appropriateness should be determined on a case-by-case basis by licensed medical professionals.